|
Serious adverse events
|
Placebo |
Dulaglutide |
|
Total subjects affected by serious adverse events
|
|
|
|
subjects affected / exposed
|
2044 / 4949 (41.30%) |
1991 / 4943 (40.28%) |
|
number of deaths (all causes)
|
277 |
242 |
|
number of deaths resulting from adverse events
|
13 |
8 |
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
|
|
|
|
acute myeloid leukaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
adenocarcinoma gastric
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
1 / 11 |
1 / 7 |
|
deaths causally related to treatment / all
|
1 / 4 |
0 / 1 |
|
adenocarcinoma of colon
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
17 / 4943 (0.34%) |
|
occurrences causally related to treatment / all
|
1 / 14 |
1 / 17 |
|
deaths causally related to treatment / all
|
0 / 1 |
1 / 4 |
|
adenocarcinoma of the cervix
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [1]
|
1 / 2282 (0.04%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adenocarcinoma pancreas
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
1 / 2 |
|
adenoma benign
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adenosquamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
adrenal adenoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adrenal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anal squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anaplastic astrocytoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anogenital warts
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
astrocytoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
b-cell lymphoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
b-cell lymphoma stage i
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
b-cell lymphoma stage ii
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
b-cell small lymphocytic lymphoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
basal cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
benign gastric neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
benign hepatic neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
benign neoplasm of adrenal gland
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
benign neoplasm of thyroid gland
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bile duct adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bile duct cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
biliary cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
bladder cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
bladder cancer recurrent
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 5 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder papilloma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder transitional cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
1 / 6 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
bladder transitional cell carcinoma recurrent
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder transitional cell carcinoma stage i
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bone cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bone cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
bone neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
borderline ovarian tumour
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [2]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bowen's disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
brain neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
brain neoplasm malignant
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
breast cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
11 / 4943 (0.22%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
1 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
breast cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
breast cancer recurrent
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
breast cancer stage iii
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
brenner tumour
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [3]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchial carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cancer pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carcinoid tumour pulmonary
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac myxoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebral haemangioma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cervix carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [4]
|
2 / 2282 (0.09%) |
4 / 2303 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
cervix carcinoma stage 0
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [5]
|
2 / 2282 (0.09%) |
0 / 2303 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholangiocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
chronic lymphocytic leukaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic myeloid leukaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
clear cell renal cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
1 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colon adenoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colon cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
2 / 5 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
colon cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colon cancer stage ii
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colon cancer stage iv
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colon neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
colorectal adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colorectal cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colorectal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diffuse large b-cell lymphoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
diffuse large b-cell lymphoma stage iv
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ductal adenocarcinoma of pancreas
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
endometrial adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [6]
|
9 / 2282 (0.39%) |
6 / 2303 (0.26%) |
|
occurrences causally related to treatment / all
|
1 / 9 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endometrial cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [7]
|
1 / 2282 (0.04%) |
3 / 2303 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
extranodal marginal zone b-cell lymphoma (malt type)
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
fibroadenoma of breast
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fibrosarcoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gallbladder cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
gallbladder squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
gastric neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
gastrointestinal stromal cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal stromal tumour
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
glioblastoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
hepatic angiosarcoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
hepatic cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
hepatic cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
hepatic neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatocellular carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
3 / 6 |
0 / 1 |
|
deaths causally related to treatment / all
|
2 / 2 |
0 / 1 |
|
hodgkin's disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
huerthle cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intraductal proliferative breast lesion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
invasive breast carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
invasive ductal breast carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
invasive lobular breast carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
keratoacanthoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
large intestine benign neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
laryngeal cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
laryngeal squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
leiomyosarcoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
leiomyosarcoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
lip squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lipoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
liposarcoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
liposarcoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
lung adenocarcinoma stage ii
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung adenocarcinoma stage iii
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung adenocarcinoma stage iv
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
lung cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
lung neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung neoplasm malignant
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
1 / 6 |
0 / 9 |
|
deaths causally related to treatment / all
|
1 / 4 |
0 / 3 |
|
lymphoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
malignant joint neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
malignant melanoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
malignant melanoma stage iii
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
malignant neoplasm of ampulla of vater
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
malignant pleural effusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mediastinum neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
medullary thyroid cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
meningeal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
meningioma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mesothelioma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
mesothelioma malignant
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to adrenals
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to bone
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to central nervous system
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
metastases to chest wall
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to kidney
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to liver
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to lung
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
metastases to lymph nodes
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to pelvis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to peritoneum
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to pleura
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastatic bronchial carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 1 |
|
metastatic gastric cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
metastatic neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
metastatic renal cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myelodysplastic syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nasal sinus cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neoplasm malignant
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
neoplasm prostate
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [8]
|
0 / 2667 (0.00%) |
3 / 2640 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neuroendocrine carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
neuroendocrine carcinoma of the skin
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neuroendocrine tumour
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
non-hodgkin's lymphoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
non-small cell lung cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
non-small cell lung cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
non-small cell lung cancer stage ii
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
non-small cell lung cancer stage iv
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
oesophageal squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ovarian adenoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [9]
|
2 / 2282 (0.09%) |
0 / 2303 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ovarian cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [10]
|
2 / 2282 (0.09%) |
0 / 2303 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ovarian cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [11]
|
1 / 2282 (0.04%) |
0 / 2303 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ovarian cancer stage iii
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [12]
|
1 / 2282 (0.04%) |
0 / 2303 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ovarian epithelial cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [13]
|
0 / 2282 (0.00%) |
2 / 2303 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatic carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
1 / 8 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
pancreatic carcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
3 / 5 |
3 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
1 / 2 |
|
pancreatic neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
papillary thyroid cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
paraganglion neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
parathyroid tumour benign
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
penile squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [14]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pericardial effusion malignant
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
phaeochromocytoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pituitary tumour
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pituitary tumour benign
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
plasma cell leukaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
plasma cell myeloma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
prostate cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [15]
|
33 / 2667 (1.24%) |
33 / 2640 (1.25%) |
|
occurrences causally related to treatment / all
|
1 / 34 |
1 / 33 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
prostate cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [16]
|
4 / 2667 (0.15%) |
2 / 2640 (0.08%) |
|
occurrences causally related to treatment / all
|
1 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
prostate cancer recurrent
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [17]
|
1 / 2667 (0.04%) |
1 / 2640 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostate cancer stage i
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [18]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostatic adenoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [19]
|
3 / 2667 (0.11%) |
6 / 2640 (0.23%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
1 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal adenoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
rectal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectosigmoid cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
1 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
renal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal oncocytoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sarcoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
small cell lung cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
small cell lung cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal meningioma benign
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spindle cell sarcoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
squamous cell carcinoma of lung
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
squamous cell carcinoma of skin
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
squamous cell carcinoma of the cervix
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [20]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
squamous cell carcinoma of the vagina
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [21]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
squamous cell carcinoma of the vulva
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [22]
|
0 / 2282 (0.00%) |
2 / 2303 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sweat gland tumour
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
throat cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
thymoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thyroid adenoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thyroid cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tongue carcinoma stage iv
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
tongue neoplasm malignant stage unspecified
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tonsil cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transitional cell cancer of the renal pelvis and ureter
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transitional cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
1 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transitional cell carcinoma recurrent
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tumour associated fever
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
tumour of ampulla of vater
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urethral cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uterine cancer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [23]
|
2 / 2282 (0.09%) |
4 / 2303 (0.17%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 1 |
|
uterine leiomyoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [24]
|
1 / 2282 (0.04%) |
3 / 2303 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uterine neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [25]
|
1 / 2282 (0.04%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular neoplasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Vascular disorders
|
|
|
|
angiodysplasia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic aneurysm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
10 / 4943 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
aortic aneurysm rupture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic arteriosclerosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic dissection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
aortic stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
16 / 4949 (0.32%) |
21 / 4943 (0.42%) |
|
occurrences causally related to treatment / all
|
0 / 17 |
0 / 21 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
arterial occlusive disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arterial stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arteriosclerosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bleeding varicose vein
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
circulatory collapse
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deep vein thrombosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
16 / 4943 (0.32%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 16 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dry gangrene
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
essential hypertension
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
extremity necrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haematoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemodynamic instability
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
hypertension
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
27 / 4949 (0.55%) |
22 / 4943 (0.45%) |
|
occurrences causally related to treatment / all
|
0 / 29 |
0 / 24 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertensive crisis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
14 / 4943 (0.28%) |
|
occurrences causally related to treatment / all
|
0 / 21 |
1 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertensive emergency
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypotension
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
2 / 7 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
hypovolaemic shock
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
iliac artery embolism
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intermittent claudication
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphatic fistula
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphoedema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neurogenic shock
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
orthostatic hypotension
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral arterial occlusive disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
25 / 4949 (0.51%) |
17 / 4943 (0.34%) |
|
occurrences causally related to treatment / all
|
0 / 26 |
0 / 18 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral artery thrombosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral embolism
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral ischaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral vascular disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
peripheral venous disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
phlebitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
shock
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
shock haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subclavian artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
superior vena cava syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
temporal arteritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombophlebitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
varicose vein
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vena cava thrombosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
venous thrombosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
venous thrombosis limb
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
General disorders and administration site conditions
|
|
|
|
adverse drug reaction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
asthenia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
1 / 5 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chest discomfort
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chest pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
1 / 15 |
1 / 7 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
death
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
1 / 9 |
1 / 9 |
|
deaths causally related to treatment / all
|
1 / 9 |
1 / 9 |
|
device intolerance
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
drug effect increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
drug intolerance
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fatigue
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
gait disturbance
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
general physical health deterioration
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
generalised oedema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hernia perforation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperthermia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
impaired healing
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
inflammation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
malaise
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metaplasia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
multiple organ dysfunction syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
necrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
non-cardiac chest pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
37 / 4949 (0.75%) |
26 / 4943 (0.53%) |
|
occurrences causally related to treatment / all
|
0 / 44 |
1 / 28 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oedema peripheral
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral swelling
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pyrexia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
strangulated hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sudden cardiac death
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
sudden death
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 5 |
0 / 3 |
|
systemic inflammatory response syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular stent occlusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular stent stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Immune system disorders
|
|
|
|
anaphylactic reaction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anti-neutrophil cytoplasmic antibody positive vasculitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
contrast media allergy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
drug hypersensitivity
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypersensitivity
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
immunodeficiency
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sarcoidosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Social circumstances
|
|
|
|
diet noncompliance
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
organ donor
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Reproductive system and breast disorders
|
|
|
|
acquired phimosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
benign prostatic hyperplasia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [26]
|
18 / 2667 (0.67%) |
21 / 2640 (0.80%) |
|
occurrences causally related to treatment / all
|
1 / 20 |
0 / 21 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
breast pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cervical polyp
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [27]
|
1 / 2282 (0.04%) |
2 / 2303 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cystocele
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [28]
|
4 / 2282 (0.18%) |
3 / 2303 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endometrial hyperplasia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [29]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endometrial hypertrophy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [30]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endometriosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [31]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
erectile dysfunction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [32]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
female genital tract fistula
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [33]
|
0 / 2282 (0.00%) |
2 / 2303 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fibrocystic breast disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
genital prolapse
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gynaecomastia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [34]
|
0 / 2667 (0.00%) |
2 / 2640 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metrorrhagia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [35]
|
0 / 2282 (0.00%) |
2 / 2303 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ovarian cyst
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [36]
|
1 / 2282 (0.04%) |
6 / 2303 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pelvic fluid collection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pelvic prolapse
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostatism
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [37]
|
2 / 2667 (0.07%) |
0 / 2640 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostatitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [38]
|
2 / 2667 (0.07%) |
4 / 2640 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostatomegaly
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [39]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectocele
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [40]
|
1 / 2282 (0.04%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uterine disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [41]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uterine polyp
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [42]
|
2 / 2282 (0.09%) |
3 / 2303 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uterine prolapse
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [43]
|
0 / 2282 (0.00%) |
3 / 2303 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uterovaginal prolapse
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [44]
|
2 / 2282 (0.09%) |
2 / 2303 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vaginal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [45]
|
1 / 2282 (0.04%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vaginal polyp
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [46]
|
1 / 2282 (0.04%) |
0 / 2303 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vaginal prolapse
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [47]
|
0 / 2282 (0.00%) |
2 / 2303 (0.09%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Respiratory, thoracic and mediastinal disorders
|
|
|
|
acquired diaphragmatic eventration
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
acute pulmonary oedema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
acute respiratory failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 17 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
alveolitis allergic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
asphyxia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
aspiration
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
asthma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 13 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atelectasis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
bronchial hyperreactivity
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchial polyp
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchitis chronic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchopneumopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic obstructive pulmonary disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
35 / 4949 (0.71%) |
25 / 4943 (0.51%) |
|
occurrences causally related to treatment / all
|
0 / 45 |
0 / 32 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
chronic respiratory failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cough
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dysphonia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dyspnoea
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
15 / 4949 (0.30%) |
11 / 4943 (0.22%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
0 / 12 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
dyspnoea exertional
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
emphysema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
epistaxis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemoptysis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemothorax
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypercapnia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperventilation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypoxia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
interstitial lung disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
13 / 4943 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
lung infiltration
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nasal polyps
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nasal septum deviation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
obstructive airways disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pharyngeal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pickwickian syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pleural effusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
13 / 4943 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pleural thickening
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pleurisy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia aspiration
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
pneumonitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumothorax
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
1 / 6 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumothorax spontaneous
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary congestion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary embolism
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
22 / 4943 (0.45%) |
|
occurrences causally related to treatment / all
|
1 / 22 |
1 / 23 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 5 |
|
pulmonary fibrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary hypertension
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
pulmonary mass
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary oedema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
20 / 4949 (0.40%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 20 |
1 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
pulmonary thrombosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
respiratory arrest
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
respiratory distress
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
respiratory failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
20 / 4949 (0.40%) |
16 / 4943 (0.32%) |
|
occurrences causally related to treatment / all
|
0 / 22 |
0 / 16 |
|
deaths causally related to treatment / all
|
0 / 6 |
0 / 5 |
|
respiratory tract oedema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
restrictive pulmonary disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rhinitis hypertrophic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sleep apnoea syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Psychiatric disorders
|
|
|
|
abnormal behaviour
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adjustment disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adjustment disorder with depressed mood
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
affective disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aggression
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
alcohol abuse
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
alcohol withdrawal syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anxiety
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anxiety disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bipolar disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
confusional state
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
delirium
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
10 / 4943 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
delusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
depression
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
1 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
depression suicidal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
disorientation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
emotional distress
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
generalised anxiety disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypomania
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
major depression
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mania
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mental disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mental status changes
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
panic disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
personality change due to a general medical condition
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
psychogenic seizure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
psychotic disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
restlessness
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
somatic delusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
somatic symptom disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
suicidal ideation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
suicide attempt
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Product issues
|
|
|
|
device damage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device dislocation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device loosening
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device malfunction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device occlusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Hepatobiliary disorders
|
|
|
|
acute hepatic failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bile duct obstruction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bile duct stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bile duct stone
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
1 / 7 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
biliary colic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
biliary dyspepsia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholangitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
2 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholangitis acute
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholangitis chronic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholecystitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
15 / 4949 (0.30%) |
25 / 4943 (0.51%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
6 / 28 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
cholecystitis acute
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
26 / 4943 (0.53%) |
|
occurrences causally related to treatment / all
|
0 / 17 |
4 / 27 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholecystitis chronic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholelithiasis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
49 / 4949 (0.99%) |
42 / 4943 (0.85%) |
|
occurrences causally related to treatment / all
|
2 / 51 |
8 / 43 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholestasis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
drug-induced liver injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gallbladder cholesterolosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gallbladder necrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gallbladder perforation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gallbladder polyp
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatic cirrhosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatic failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
hepatic mass
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatic steatosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
2 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatorenal syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
ischaemic hepatitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
jaundice
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
jaundice cholestatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
liver disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
non-alcoholic fatty liver
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
non-alcoholic steatohepatitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
portal hypertension
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
portal vein thrombosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post cholecystectomy syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Investigations
|
|
|
|
amylase increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anticoagulation drug level above therapeutic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood calcitonin increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood calcium increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood creatinine increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood glucose decreased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood glucose fluctuation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood glucose increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood pressure increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
c-reactive protein increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coagulation test abnormal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
electrocardiogram abnormal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gamma-glutamyltransferase increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
glomerular filtration rate decreased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
glycosylated haemoglobin increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemoglobin decreased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatic enzyme increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oxygen saturation decreased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transaminases increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
troponin t increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
troponin increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urine albumin/creatinine ratio increased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
weight decreased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Injury, poisoning and procedural complications
|
|
|
|
accident
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
accident at work
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
accidental overdose
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
acetabulum fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
alcohol poisoning
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anaemia postoperative
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anastomotic complication
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anastomotic leak
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ankle fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
20 / 4949 (0.40%) |
21 / 4943 (0.42%) |
|
occurrences causally related to treatment / all
|
0 / 20 |
0 / 21 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arterial injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arteriovenous fistula occlusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arthropod bite
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
back injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
brain contusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
burns second degree
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
burns third degree
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carbon monoxide poisoning
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cartilage injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cervical vertebral fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chemical poisoning
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
clavicle fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
concussion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
contusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary vascular graft occlusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
craniocerebral injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
craniofacial fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
deep vein thrombosis postoperative
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
delayed recovery from anaesthesia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
facial bones fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
failure to anastomose
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
fall
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
124 / 4949 (2.51%) |
110 / 4943 (2.23%) |
|
occurrences causally related to treatment / all
|
0 / 137 |
2 / 123 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
femoral neck fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
femur fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
18 / 4943 (0.36%) |
|
occurrences causally related to treatment / all
|
0 / 22 |
0 / 18 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
fibula fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
foot fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
forearm fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
foreign body
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
foreign body aspiration
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
foreign body in gastrointestinal tract
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastroenteritis radiation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal stoma complication
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
graft thrombosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gun shot wound
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hand fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
head injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hip fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
12 / 4943 (0.24%) |
|
occurrences causally related to treatment / all
|
0 / 17 |
0 / 12 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
humerus fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
20 / 4949 (0.40%) |
12 / 4943 (0.24%) |
|
occurrences causally related to treatment / all
|
1 / 20 |
0 / 12 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyphaema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
incisional hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
incisional hernia, obstructive
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intentional overdose
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intestinal anastomosis complication
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
jaw fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
joint dislocation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
joint injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
laceration
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ligament rupture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ligament sprain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
limb crushing injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
limb injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lower limb fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lumbar vertebral fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lumbosacral plexus injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
meniscus injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
12 / 4943 (0.24%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 12 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
multiple fractures
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
multiple injuries
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
muscle rupture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
muscle strain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
overdose
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
patella fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pelvic fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
periprosthetic fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumothorax traumatic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post concussion syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural bile leak
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural complication
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
post procedural discharge
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural haematoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural haematuria
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural swelling
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post-traumatic pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative adhesion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative delirium
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative thoracic procedure complication
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative wound complication
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
procedural hypotension
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
procedural pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pubis fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
radiation pneumonitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
radius fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rib fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
10 / 4943 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 14 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
road traffic accident
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
13 / 4943 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
scapula fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sciatic nerve injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
scrotal haematoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [48]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skin injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skull fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skull fractured base
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
soft tissue injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal compression fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal cord injury cervical
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
splenic rupture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
stab wound
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sternal fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
stoma site haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subarachnoid haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subdural haematoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
subdural haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
suture rupture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tendon injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tendon rupture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thermal burn
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thoracic vertebral fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tibia fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tongue injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
toxicity to various agents
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transfusion-related acute lung injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
traumatic fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
traumatic haematoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
traumatic haemothorax
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
traumatic intracranial haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ulna fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
upper limb fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular graft occlusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular pseudoaneurysm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
wound
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound dehiscence
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound secretion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wrist fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Congenital, familial and genetic disorders
|
|
|
|
adenomatous polyposis coli
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrial septal defect
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic granulomatous disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
congenital cerebrovascular anomaly
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
developmental hip dysplasia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
exomphalos
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal arteriovenous malformation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
heart disease congenital
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hereditary motor and sensory neuropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hydrocele
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [49]
|
0 / 2667 (0.00%) |
2 / 2640 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertrophic cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
phimosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [50]
|
1 / 2667 (0.04%) |
3 / 2640 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular malformation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Cardiac disorders
|
|
|
|
acute coronary syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
41 / 4949 (0.83%) |
43 / 4943 (0.87%) |
|
occurrences causally related to treatment / all
|
0 / 43 |
0 / 44 |
|
deaths causally related to treatment / all
|
0 / 9 |
0 / 7 |
|
acute left ventricular failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
acute myocardial infarction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
53 / 4949 (1.07%) |
39 / 4943 (0.79%) |
|
occurrences causally related to treatment / all
|
4 / 59 |
0 / 40 |
|
deaths causally related to treatment / all
|
0 / 14 |
0 / 15 |
|
angina pectoris
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
58 / 4949 (1.17%) |
56 / 4943 (1.13%) |
|
occurrences causally related to treatment / all
|
1 / 67 |
1 / 61 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
angina unstable
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
54 / 4949 (1.09%) |
44 / 4943 (0.89%) |
|
occurrences causally related to treatment / all
|
1 / 58 |
1 / 47 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
aortic valve disease mixed
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic valve incompetence
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic valve stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arrhythmia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
arteriosclerosis coronary artery
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
atrial fibrillation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
62 / 4949 (1.25%) |
90 / 4943 (1.82%) |
|
occurrences causally related to treatment / all
|
2 / 79 |
3 / 107 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrial flutter
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
18 / 4949 (0.36%) |
15 / 4943 (0.30%) |
|
occurrences causally related to treatment / all
|
1 / 19 |
1 / 19 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrial tachycardia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrial thrombosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrioventricular block
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
atrioventricular block complete
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrioventricular block first degree
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrioventricular block second degree
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
1 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bifascicular block
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bradyarrhythmia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bradycardia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
16 / 4943 (0.32%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 17 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bundle branch block left
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bundle branch block right
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac arrest
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
11 / 4943 (0.22%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
0 / 14 |
|
deaths causally related to treatment / all
|
0 / 7 |
0 / 6 |
|
cardiac disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
104 / 4949 (2.10%) |
78 / 4943 (1.58%) |
|
occurrences causally related to treatment / all
|
3 / 124 |
2 / 87 |
|
deaths causally related to treatment / all
|
0 / 21 |
0 / 10 |
|
cardiac failure acute
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
cardiac failure chronic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
14 / 4943 (0.28%) |
|
occurrences causally related to treatment / all
|
0 / 24 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
cardiac failure congestive
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
47 / 4949 (0.95%) |
38 / 4943 (0.77%) |
|
occurrences causally related to treatment / all
|
5 / 52 |
4 / 42 |
|
deaths causally related to treatment / all
|
0 / 4 |
0 / 8 |
|
cardiac tamponade
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardio-respiratory arrest
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
1 / 7 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
cardiogenic shock
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
cardiomyopathy alcoholic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiopulmonary failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
cardiorenal syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiovascular disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiovascular insufficiency
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic left ventricular failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
congestive cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cor pulmonale
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary artery disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
57 / 4949 (1.15%) |
57 / 4943 (1.15%) |
|
occurrences causally related to treatment / all
|
1 / 64 |
0 / 63 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
coronary artery insufficiency
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary artery perforation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
defect conduction intraventricular
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diastolic dysfunction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dressler's syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
extrasystoles
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrocardiac syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertensive heart disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ischaemic cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
10 / 4943 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
left ventricular dysfunction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
left ventricular failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
13 / 4943 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metabolic cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
microvascular coronary artery disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mitral valve disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mitral valve incompetence
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mitral valve prolapse
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mitral valve stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myocardial infarction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
35 / 4949 (0.71%) |
30 / 4943 (0.61%) |
|
occurrences causally related to treatment / all
|
0 / 37 |
4 / 30 |
|
deaths causally related to treatment / all
|
0 / 8 |
2 / 8 |
|
myocardial ischaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
23 / 4949 (0.46%) |
19 / 4943 (0.38%) |
|
occurrences causally related to treatment / all
|
0 / 23 |
0 / 20 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
myocarditis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nodal rhythm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
palpitations
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pericardial effusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pericarditis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
1 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prinzmetal angina
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
right ventricular dysfunction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
right ventricular failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
silent myocardial infarction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sinoatrial block
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sinus arrest
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sinus bradycardia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sinus node dysfunction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sinus tachycardia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
stress cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
supraventricular extrasystoles
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
supraventricular tachycardia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tachyarrhythmia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tachycardia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
2 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tachycardia induced cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tricuspid valve incompetence
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ventricular arrhythmia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
ventricular extrasystoles
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ventricular fibrillation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
ventricular tachycardia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Nervous system disorders
|
|
|
|
acoustic neuritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
altered state of consciousness
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
amnesia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
amputation stump pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aphasia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ataxia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
autonomic nervous system imbalance
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
balance disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
basal ganglia haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
brain injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
brain stem haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
brain stem infarction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
carotid arteriosclerosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid sinus syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carpal tunnel syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cauda equina syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebellar ataxia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebellar atrophy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebellar infarction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebral arteriosclerosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
cerebral atrophy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebral circulatory failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebral haematoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebral haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
cerebral infarction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebral ischaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebrovascular accident
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
31 / 4949 (0.63%) |
24 / 4943 (0.49%) |
|
occurrences causally related to treatment / all
|
1 / 34 |
0 / 25 |
|
deaths causally related to treatment / all
|
1 / 2 |
0 / 1 |
|
cerebrovascular disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
cerebrovascular insufficiency
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cervical radiculopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cervicobrachial syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cognitive disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dementia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dementia alzheimer's type
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
demyelinating polyneuropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
depressed level of consciousness
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic coma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
diabetic hyperglycaemic coma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic hyperosmolar coma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic mononeuropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic neuropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dizziness
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dizziness postural
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dysarthria
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
embolic stroke
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
epilepsy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
facial paralysis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
frontal lobe epilepsy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
generalised tonic-clonic seizure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
guillain-barre syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhage intracranial
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
haemorrhagic cerebral infarction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhagic stroke
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
headache
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hemiparesis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hemiplegia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hydrocephalus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertensive encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypoaesthesia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
iiird nerve paralysis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intracranial aneurysm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intracranial haematoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ischaemic cerebral infarction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
ischaemic neuropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ischaemic stroke
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
18 / 4949 (0.36%) |
14 / 4943 (0.28%) |
|
occurrences causally related to treatment / all
|
1 / 22 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 5 |
0 / 1 |
|
lacunar infarction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lacunar stroke
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
language disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
loss of consciousness
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lumbar radiculopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lumbosacral radiculopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metabolic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
migraine
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mixed dementia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
monoparesis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
motor neurone disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
myasthenia gravis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myelopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myoclonus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nerve root compression
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nervous system disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neuritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neuropathy peripheral
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
normal pressure hydrocephalus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
optic neuritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
paralysis recurrent laryngeal nerve
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
parkinson's disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
parkinsonism
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
partial seizures
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral nerve paresis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral sensorimotor neuropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peroneal nerve palsy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
piriformis syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
polyneuropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post herpetic neuralgia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
presyncope
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pseudobulbar palsy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
psychomotor hyperactivity
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
quadriplegia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
radiculopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sciatica
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
seizure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sensory disturbance
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
serotonin syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal claudication
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
syncope
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
33 / 4949 (0.67%) |
36 / 4943 (0.73%) |
|
occurrences causally related to treatment / all
|
1 / 34 |
5 / 38 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
thrombotic stroke
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
toxic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transient global amnesia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transient ischaemic attack
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
23 / 4949 (0.46%) |
22 / 4943 (0.45%) |
|
occurrences causally related to treatment / all
|
0 / 24 |
0 / 25 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tremor
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
trigeminal neuralgia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uraemic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vith nerve paralysis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular dementia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular parkinsonism
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vertebrobasilar insufficiency
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wernicke's encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Blood and lymphatic system disorders
|
|
|
|
agranulocytosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
23 / 4949 (0.46%) |
29 / 4943 (0.59%) |
|
occurrences causally related to treatment / all
|
1 / 24 |
0 / 30 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anaemia folate deficiency
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anaemia macrocytic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anaemia of malignant disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anaemia vitamin b12 deficiency
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
deficiency anaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
disseminated intravascular coagulation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
febrile neutropenia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
haemolytic anaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhagic anaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
histiocytosis haematophagic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypochromic anaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
immune thrombocytopenic purpura
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
iron deficiency anaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
14 / 4943 (0.28%) |
|
occurrences causally related to treatment / all
|
1 / 10 |
0 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphadenopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphadenopathy mediastinal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
microcytic anaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nephrogenic anaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neutropenia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
normochromic normocytic anaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
normocytic anaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancytopenia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
polycythaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
splenic haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
splenomegaly
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombocytopenia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Ear and labyrinth disorders
|
|
|
|
deafness
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
deafness neurosensory
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
deafness unilateral
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypoacusis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sudden hearing loss
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vertigo
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vertigo positional
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vestibular ataxia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vestibular disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Eye disorders
|
|
|
|
amaurosis fugax
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
amblyopia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
angle closure glaucoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blepharochalasis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cataract
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
29 / 4949 (0.59%) |
19 / 4943 (0.38%) |
|
occurrences causally related to treatment / all
|
0 / 34 |
0 / 27 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cataract diabetic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cataract nuclear
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cataract subcapsular
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dacryostenosis acquired
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic retinopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diplopia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
eye haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
glaucoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypermetropia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
iridodialysis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lens dislocation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
macular fibrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
macular hole
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
macular oedema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
maculopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neurotrophic keratopathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
open angle glaucoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ophthalmic vein thrombosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
optic ischaemic neuropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retinal artery embolism
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retinal artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retinal detachment
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retinal tear
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
strabismus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vitreous haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Gastrointestinal disorders
|
|
|
|
abdominal adhesions
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal compartment syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal discomfort
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal hernia obstructive
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal incarcerated hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal mass
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
10 / 4943 (0.20%) |
|
occurrences causally related to treatment / all
|
1 / 11 |
1 / 12 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
abdominal pain upper
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal wall haematoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
acute abdomen
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anal fistula
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anal incontinence
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ascites
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
barrett's oesophagus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic gastritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colitis ischaemic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colitis microscopic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colitis ulcerative
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
constipation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
crohn's disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dental cyst
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic gastroparesis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diaphragmatic hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diarrhoea
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
10 / 4943 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
4 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diverticular perforation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diverticulum
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diverticulum intestinal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diverticulum intestinal haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
duodenal ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
duodenal ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
duodenitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dyspepsia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dysphagia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
enteritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
enterovesical fistula
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
erosive duodenitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
faecaloma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fistula of small intestine
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
food poisoning
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gallstone ileus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric dilatation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric dysplasia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric polyps
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
13 / 4943 (0.26%) |
|
occurrences causally related to treatment / all
|
1 / 17 |
3 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastritis erosive
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastroduodenitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
13 / 4949 (0.26%) |
12 / 4943 (0.24%) |
|
occurrences causally related to treatment / all
|
1 / 14 |
1 / 13 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
gastrointestinal inflammation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal motility disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal mucocoele
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal necrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal polyp
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal polyp haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
gastrointestinal ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal vascular malformation haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrooesophageal reflux disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haematemesis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haematochezia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhagic erosive gastritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhoidal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhoids
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhoids thrombosed
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hernial eventration
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
heyde's syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hiatus hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ileus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ileus paralytic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
impaired gastric emptying
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
incarcerated inguinal hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
incarcerated umbilical hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
inguinal hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
17 / 4943 (0.34%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 17 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
intestinal ischaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
intestinal mass
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intestinal obstruction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
1 / 15 |
2 / 9 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
intestinal perforation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intestinal polyp
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intestinal stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intra-abdominal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
intussusception
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
irritable bowel syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
large intestine perforation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
large intestine polyp
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lower gastrointestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mallory-weiss syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mechanical ileus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
megacolon
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
melaena
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mesenteric arterial occlusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mesenteric artery thrombosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mouth haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nausea
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
necrotising oesophagitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
obstructive pancreatitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal achalasia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal spasm
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal varices haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophagitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
palatal disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatic cyst
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatic pseudocyst
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
1 / 5 |
5 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatitis acute
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
15 / 4943 (0.30%) |
|
occurrences causally related to treatment / all
|
5 / 10 |
5 / 15 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
pancreatitis chronic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peptic ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peritoneal adhesions
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peritoneal haematoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peritoneal hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
portal venous gas
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
proctitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal polyp
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retroperitoneal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
salivary gland calculus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
small intestinal obstruction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spigelian hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
strangulated umbilical hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombosis mesenteric vessel
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
umbilical hernia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
umbilical hernia, obstructive
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
upper gastrointestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
1 / 7 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
varices oesophageal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
volvulus of small bowel
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vomiting
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
2 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Skin and subcutaneous tissue disorders
|
|
|
|
angioedema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
decubitus ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
dermatitis allergic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dermatitis atopic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic foot
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
19 / 4949 (0.38%) |
14 / 4943 (0.28%) |
|
occurrences causally related to treatment / all
|
0 / 24 |
0 / 17 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
diabetic neuropathic ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
erythrodermic psoriasis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypersensitivity vasculitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ischaemic skin ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neuropathic ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pemphigoid
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
psoriasis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pyoderma gangrenosum
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rash generalised
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rash papular
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skin disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skin lesion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skin ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
15 / 4949 (0.30%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 16 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
stasis dermatitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subcutaneous emphysema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urticaria
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vasculitic ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Renal and urinary disorders
|
|
|
|
acute kidney injury
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
67 / 4949 (1.35%) |
61 / 4943 (1.23%) |
|
occurrences causally related to treatment / all
|
7 / 74 |
2 / 72 |
|
deaths causally related to treatment / all
|
1 / 7 |
1 / 2 |
|
atonic urinary bladder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
azotaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder dysfunction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder fibrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder hypertrophy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder mass
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder neck obstruction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder neck sclerosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder obstruction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder outlet obstruction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
calculus bladder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
calculus urethral
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
calculus urinary
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic kidney disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
19 / 4949 (0.38%) |
13 / 4943 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 20 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
cystitis haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic nephropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
dysuria
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
end stage renal disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
2 / 6 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
haematuria
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhage urinary tract
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hydronephrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hydroureter
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertensive nephropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertonic bladder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
kidney perforation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nephrolithiasis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
18 / 4943 (0.36%) |
|
occurrences causally related to treatment / all
|
0 / 18 |
0 / 19 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nephropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pelvi-ureteric obstruction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
proteinuria
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal colic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
1 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal cyst
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal failure
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
16 / 4943 (0.32%) |
|
occurrences causally related to treatment / all
|
1 / 17 |
0 / 16 |
|
deaths causally related to treatment / all
|
1 / 6 |
0 / 4 |
|
renal haematoma
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal impairment
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
renal infarct
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
renal mass
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
stress urinary incontinence
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tubulointerstitial nephritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ureteric dilatation
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ureteric stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ureterolithiasis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urethral caruncle
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urethral disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urethral stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary bladder polyp
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary incontinence
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary retention
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
1 / 9 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary tract obstruction
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Endocrine disorders
|
|
|
|
acromegaly
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adrenal insufficiency
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adrenocortical insufficiency acute
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
autoimmune thyroiditis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cushing's syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
goitre
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
12 / 4943 (0.24%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
1 / 12 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperaldosteronism
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperparathyroidism
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperparathyroidism primary
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperparathyroidism secondary
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperthyroidism
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypoparathyroidism secondary
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
parathyroid disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
primary hyperaldosteronism
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thyroid mass
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thyroiditis subacute
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
toxic nodular goitre
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Musculoskeletal and connective tissue disorders
|
|
|
|
arthralgia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
9 / 4943 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arthritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arthritis reactive
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arthrofibrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arthropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
articular calcification
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
back pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bone lesion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bursitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cervical spinal stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chondrocalcinosis pyrophosphate
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chondromalacia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chondropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
costochondritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic amyotrophy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic arthropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dupuytren's contracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
exostosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fistula
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
foot deformity
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fracture malunion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gouty arthritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gouty tophus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intervertebral disc degeneration
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intervertebral disc disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intervertebral disc protrusion
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
15 / 4943 (0.30%) |
|
occurrences causally related to treatment / all
|
0 / 22 |
0 / 16 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
joint ankylosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
joint noise
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
joint swelling
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lumbar spinal stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
10 / 4943 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 14 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mobility decreased
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
muscle haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
muscle spasms
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
muscular weakness
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
musculoskeletal chest pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
10 / 4943 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
musculoskeletal pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myalgia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neck pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neuropathic arthropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteitis deformans
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteoarthritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
110 / 4949 (2.22%) |
136 / 4943 (2.75%) |
|
occurrences causally related to treatment / all
|
0 / 128 |
0 / 155 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteochondrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteonecrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteopenia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteoporosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pain in extremity
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
patellofemoral pain syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pathological fracture
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
periarthritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
plantar fascial fibromatosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
polymyalgia rheumatica
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pseudarthrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rhabdomyolysis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rheumatic disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rheumatoid arthritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rotator cuff syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal column stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
13 / 4943 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal osteoarthritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
16 / 4943 (0.32%) |
|
occurrences causally related to treatment / all
|
0 / 23 |
0 / 19 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
spinal pain
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spondylitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spondyloarthropathy
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spondylolisthesis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spondylolysis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
synovial cyst
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
synovitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tendon disorder
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tendonitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tenosynovitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vertebral foraminal stenosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vertebral osteophyte
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Infections and infestations
|
|
|
|
abdominal abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abscess intestinal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abscess limb
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abscess neck
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abscess oral
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anal abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anal infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortitis salmonella
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
appendiceal abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
appendicitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
appendicitis perforated
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arthritis bacterial
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arthritis infective
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atypical pneumonia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
bacteraemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
bacterial infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
biliary sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
brain abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
breast abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
breast cellulitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
12 / 4949 (0.24%) |
13 / 4943 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
bronchitis bacterial
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchitis fungal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchitis viral
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
burn infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
campylobacter gastroenteritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
candida sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
candiduria
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carbuncle
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cellulitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
42 / 4949 (0.85%) |
38 / 4943 (0.77%) |
|
occurrences causally related to treatment / all
|
0 / 48 |
0 / 39 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
cellulitis streptococcal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cervicitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [51]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholecystitis infective
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic hepatitis b
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
clostridium colitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
clostridium difficile colitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
clostridium difficile infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
corneal abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cystitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cystitis escherichia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cytomegalovirus colitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dengue fever
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dengue haemorrhagic fever
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device related infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device related sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
diabetic foot infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic gangrene
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diarrhoea infectious
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diverticulitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
15 / 4943 (0.30%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
1 / 17 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dysentery
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
echinococciasis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
empyema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endocarditis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endocarditis bacterial
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
enterococcal sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
enterocolitis bacterial
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
epididymitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [52]
|
0 / 2667 (0.00%) |
4 / 2640 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
erysipelas
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
15 / 4949 (0.30%) |
11 / 4943 (0.22%) |
|
occurrences causally related to treatment / all
|
0 / 18 |
0 / 12 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
escherichia bacteraemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
escherichia sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
escherichia urinary tract infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
extradural abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
gallbladder abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gallbladder empyema
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gangrene
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 18 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastroenteritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
21 / 4943 (0.42%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
1 / 22 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
gastroenteritis clostridial
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastroenteritis norovirus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastroenteritis viral
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
genitourinary tract infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
groin abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
h1n1 influenza
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
haematoma infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
helicobacter gastritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
helicobacter infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatitis b
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatitis c
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatitis e
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatitis infectious mononucleosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
herpes zoster
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
herpes zoster meningoencephalitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
herpes zoster pharyngitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hydrocele male infected
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [53]
|
0 / 2667 (0.00%) |
1 / 2640 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
implant site infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infected skin ulcer
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infectious colitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infective exacerbation of chronic obstructive airways disease
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
influenza
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
injection site abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intervertebral discitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intestinal sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
joint abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
kidney infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
labyrinthitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
laryngitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
liver abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
localised infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
lower respiratory tract infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
12 / 4943 (0.24%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lower respiratory tract infection bacterial
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lower respiratory tract infection viral
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphangitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mastitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mastoiditis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mediastinitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
medical device site infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
medical device site joint infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
meningitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
meningitis aseptic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myiasis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
necrotising fasciitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neutropenic sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal candidiasis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
orchitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [54]
|
2 / 2667 (0.07%) |
3 / 2640 (0.11%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteomyelitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
10 / 4943 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 13 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteomyelitis acute
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteomyelitis chronic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
otitis externa
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
otitis media chronic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatic abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
paronychia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pelvic abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pelvic infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
perihepatic abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
perineal abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
periodontitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
perirectal abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peritonitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pharyngeal abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
151 / 4949 (3.05%) |
135 / 4943 (2.73%) |
|
occurrences causally related to treatment / all
|
0 / 174 |
1 / 152 |
|
deaths causally related to treatment / all
|
0 / 15 |
0 / 14 |
|
pneumonia bacterial
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia influenzal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia klebsiella
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia legionella
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia streptococcal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia viral
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural pneumonia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
postoperative wound infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
pseudomonal sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary mycosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
pulmonary tuberculosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pyelitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pyelonephritis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
15 / 4949 (0.30%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pyelonephritis acute
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
7 / 4943 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pyelonephritis chronic
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pyonephrosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal cyst infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
respiratory syncytial virus infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
respiratory tract infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
salmonella sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
salmonellosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
scrotal infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed [55]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
35 / 4949 (0.71%) |
30 / 4943 (0.61%) |
|
occurrences causally related to treatment / all
|
2 / 37 |
0 / 33 |
|
deaths causally related to treatment / all
|
1 / 7 |
0 / 4 |
|
septic shock
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
22 / 4949 (0.44%) |
15 / 4943 (0.30%) |
|
occurrences causally related to treatment / all
|
0 / 24 |
0 / 16 |
|
deaths causally related to treatment / all
|
0 / 9 |
0 / 5 |
|
sinusitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skin graft infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skin infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
soft tissue infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
staphylococcal bacteraemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
staphylococcal infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
staphylococcal mediastinitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
staphylococcal sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
staphylococcal skin infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
streptococcal bacteraemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subcutaneous abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subdiaphragmatic abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
systemic candida
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tooth abscess
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tracheobronchitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tuberculosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tuberculosis gastrointestinal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
upper respiratory tract infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary tract infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
61 / 4949 (1.23%) |
64 / 4943 (1.29%) |
|
occurrences causally related to treatment / all
|
2 / 65 |
0 / 78 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
urinary tract infection bacterial
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary tract infection pseudomonal
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urosepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
19 / 4949 (0.38%) |
24 / 4943 (0.49%) |
|
occurrences causally related to treatment / all
|
0 / 20 |
1 / 26 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
vestibular neuronitis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
viraemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
viral infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
viral myocarditis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound infection
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound sepsis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Metabolism and nutrition disorders
|
|
|
|
abnormal loss of weight
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cachexia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
decreased appetite
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dehydration
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
23 / 4943 (0.47%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
3 / 24 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
diabetes mellitus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetes mellitus inadequate control
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic ketoacidosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
electrolyte imbalance
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
failure to thrive
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fluid overload
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
food intolerance
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gout
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
4 / 4943 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypercalcaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperglycaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
67 / 4949 (1.35%) |
46 / 4943 (0.93%) |
|
occurrences causally related to treatment / all
|
3 / 75 |
0 / 52 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
hyperglycaemic hyperosmolar nonketotic syndrome
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperkalaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
12 / 4949 (0.24%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
hyperosmolar state
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
hypocalcaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypoglycaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
72 / 4949 (1.45%) |
62 / 4943 (1.25%) |
|
occurrences causally related to treatment / all
|
34 / 80 |
31 / 69 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypokalaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
6 / 4943 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypomagnesaemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyponatraemia
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
8 / 4943 (0.16%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
iron deficiency
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ketoacidosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lactic acidosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metabolic acidosis
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
obesity
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
5 / 4943 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
type 2 diabetes mellitus
|
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |